Stefano Dalmiani

Dr. Stefano Dalmiani

FTGM - Monasterio Foundation
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
Alessia PepeAlessia Pepe
Alessia Pepe
Laura PistoiaLaura Pistoia
Laura Pistoia
MGMaria Rita Gamberini
Maria Rita Gamberini
LCLiana Cuccia
Liana Cuccia
RLRoberto Lisi
Roberto Lisi
Antonella MeloniAntonella Meloni
Antonella Meloni
A tailored chelation therapy guided by magnetic resonance imaging (MRI) is a strategy to improve the prognosis in iron-loaded patients, in many cases still hampered by limited MRI availability. In order to address this issue, the Myocardial Iron Overload in Thalassemia (MIOT) network was established in Italy and we aimed to describe the impact of 10-year activity of this network on cardiac burden in thalassemia major (TM). Within the MIOT network, 1746 TM patients (911 females; mean age 31.2 ± 9.1 years) were consecutively enrolled and prospectively followed by 70 thalassemia and 10 MRI centres. Patients were scanned using a multiparametric approach for assessing myocardial iron overload (MIO), biventricular function, and myocardial fibrosis. At the last MRI scan, a significant increase in global heart T2* values and a significantly higher frequency of patients with no MIO (all segmental T2* ≥20 ms) were detected, with a concordant improvement in biventricular function, particularly in patients with baseline global heart T2* <20 ms. Forty-seven percentage of patients changed the chelation regimen based on MRI. The frequency of heart failure (HF) significantly decreased after baseline MRI from 3.5 to 0.8% (P < 0.0001). Forty-six patients died during the study, and HF accounted for 34.8% of deaths. Over 10 years, continuous monitoring of cardiac iron and a tailored chelation therapy allowed MIO reduction, with consequent improvement of cardiac function and reduction of cardiac complications and mortality from MIO-related HF. A national networking for rare diseases therefore proved effective in improving the care and reducing cardiac outcomes of TM patients. A national clinical and imaging networking for the continuous and standardized monitoring of the cardiac iron levels was effective in improving the care and in reducing the cardiac complications and mortality in thalassemia major patients.

11 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Giancarlo TrimarchiGiancarlo Trimarchi
Giancarlo Trimarchi
Fausto PizzinoFausto Pizzino
Fausto Pizzino
ALAlessio Lilli
Alessio Lilli
ACAlberto Ranieri De Caterina
Alberto Ranieri De Caterina
AEAugusto esposito
Augusto esposito
Umberto ParadossiUmberto Paradossi
Umberto Paradossi
Background: The advanced lung cancer inflammation index (ALI) is an independent prognostic biomarker used to assess inflammation and nutritional status in various cancers, heart failure, and acute coronary syndromes. This study investigates the prognostic significance of ALI in patients experiencing ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI), comparing its predictive abilities with the established Neutrophil-Lymphocyte Ratio (NLR). Methods: We conducted a retrospective analysis of 1171 patients from the Matrix Registry, encompassing demographic and clinical data for STEMI cases treated with pPCI, and ALI was determined using the formula [serum albumin (g/dL) × body mass index (kg/m2)]/NLR at the time of hospital admission. The primary outcome was all-cause mortality. Results: Of the 1171 patients, 86 died during the follow-up period. Univariate analysis identified age, female gender, smoking, hypertension, diabetes, prior myocardial infarction (PMI), lower left ventricular ejection fraction (LVEF), and reduced ALI as factors associated with mortality. Multivariate analysis confirmed age (HR: 1.1, 95% CI: 1.05–1.11, p < 0.001) and PMI (HR: 2.4, 95% CI: 1.4–4.3, p = 0.001) as prominent independent predictors, alongside ALI (HR: 0.95, 95% CI: 0.92–0.97, p < 0.001) and LVEF (HR: 0.98, 95% CI: 0.97–0.99, p = 0.04). An ALI cut-off of ≤10 indicated a higher mortality risk (HR: 2.3, 95% CI: 1.5–3.7, p < 0.001). The area under the curve for ALI (0.732) surpassed that for NLR (0.685), demonstrating ALI’s superior predictive capability. Conclusions: ALI is an independent prognostic factor for all-cause mortality in STEMI patients undergoing pPCI, showing greater discriminatory power than NLR, particularly in patients with ALI values ≤ 10, who face a 2.3-fold higher mortality risk.

24 March 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AGAmelie GYRARD
Amelie GYRARD
SASomayeh Abedian
Somayeh Abedian
PGPhilip Gribbon
Philip Gribbon
GMGeorge Manias
George Manias
RNRick van Nuland
Rick van Nuland
RHRada Hussein
Rada Hussein
The adoption of the European Health Data Space (EHDS) regulation has made integrating health data critical for both primary and secondary applications. Primary use cases include patient diagnosis, prognosis, and treatment, while secondary applications support research, innovation, and regulatory decision-making. Additionally, leveraging large datasets improves training quality for artificial intelligence (AI) models, particularly in cancer prevention, prediction, and treatment personalization. The European Union (EU) has recently funded multiple projects under Europe’s Beating Cancer Plan. However, these projects face challenges related to fragmentation and the lack of standardization in metadata, data storage, access, and processing. This paper examines interoperability standards used in six EU-funded cancer-related projects: IDERHA (Integration of Heterogeneous Data and Evidence Towards Regulatory and Health Technology Assessments Acceptance), EUCAIM (European Cancer Imaging Initiative), ASCAPE (Artificial Intelligence Supporting Cancer Patients Across Europe), iHelp, BigPicture, and the HealthData@EU pilot. These initiatives aim to enhance the analysis of heterogeneous health data while aligning with EHDS implementation, specifically for the EHDS for the secondary use of data (EHDS2). Between October 2023 and July 2024, we organized meetings and workshops among these projects to assess how they adopt health standards and apply Internet of Things (IoT) semantic interoperability. The discussions focused on interoperability standards for health data, knowledge graphs, the data quality framework, patient-generated health data, AI reasoning, federated approaches, security, and privacy. Based on our findings, we developed a template for designing the EHDS2 interoperability framework in alignment with the new European Interoperability Framework (EIF) and EHDS governance standards. This template maps EHDS2-recommended standards to the EIF model and principles, linking the proposed EHDS2 data quality framework to relevant International Organization for Standardization (ISO) standards. Using this template, we analyzed and compared how the recommended EHDS2 standards were implemented across the studied projects. During workshops, project teams shared insights on overcoming interoperability challenges and their innovative approaches to bridging gaps in standardization. With support from HSbooster.eu, we facilitated collaboration among these projects to exchange knowledge on standards, legal implementation, project sustainability, and harmonization with EHDS2. The findings from this work, including the created template and lessons learned, will be compiled into an interactive toolkit for the EHDS2 interoperability framework. This toolkit will help existing and future projects align with EHDS2 technical and legal requirements, serving as a foundation for a common EHDS2 interoperability framework. Additionally, standardization efforts include participation in the development of ISO/IEC 21823-3:2021—Semantic Interoperability for IoT Systems. Since no ISO standard currently exists for digital pathology and AI-based image analysis for medical diagnostics, the BigPicture project is contributing to ISO/PWI 24051-2, which focuses on digital pathology and AI-based, whole-slide image analysis. Integrating these efforts with ongoing ISO initiatives can enhance global standardization and facilitate widespread adoption across health care systems.

26 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Antonella MeloniAntonella Meloni
Antonella Meloni
Laura PistoiaLaura Pistoia
Laura Pistoia
MGMaria Rita Gamberini
Maria Rita Gamberini
Paolo RicchiPaolo Ricchi
Paolo Ricchi
VCValerio Cecinati
Valerio Cecinati
Alessia PepeAlessia Pepe
Alessia Pepe
In thalassemia major, pancreatic iron was demonstrated as a powerful predictor not only for the alterations of glucose metabolism but also for cardiac iron, fibrosis, and complications, supporting a profound link between pancreatic iron and heart disease. We determined for the first time the prevalence of pancreatic iron overload (IO) in thalassemia intermedia (TI) and systematically explored the link between pancreas T2* values and glucose metabolism and cardiac outcomes. We considered 221 beta-TI patients (53.2% females, 42.95 ± 13.74 years) consecutively enrolled in the Extension–Myocardial Iron Overload in Thalassemia project. Magnetic Resonance Imaging was used to quantify IO (T2* technique) and biventricular function and to detect replacement myocardial fibrosis. The glucose metabolism was assessed by the oral glucose tolerance test (OGTT). Pancreatic IO was more frequent in regularly transfused (N = 145) than in nontransfused patients (67.6% vs. 31.6%; p < 0.0001). In the regular transfused group, splenectomy and hepatitis C virus infection were both associated with high pancreatic siderosis. Patients with normal glucose metabolism showed significantly higher global pancreas T2* values than patients with altered OGTT. A pancreas T2* < 17.9 ms predicted an abnormal OGTT. A normal pancreas T2* value showed a 100% negative predictive value for cardiac iron. Pancreas T2* values were not associated to biventricular function, replacement myocardial fibrosis, or cardiac complications. Our findings suggest that in the presence of pancreatic IO, it would be prudent to initiate or intensify iron chelation therapy to prospectively prevent both disturbances of glucose metabolism and cardiac iron accumulation.

12 April 2024 in Buildings
Verified
Journal Article
Open access
PDF file
Alessandro FrancoAlessandro Franco
Alessandro Franco
ECEmanuele Crisostomi
Emanuele Crisostomi
Stefano DalmianiStefano Dalmiani
Stefano Dalmiani
RPRoberta Poletti
Roberta Poletti
Shared public buildings have become centers of innovation, integrating advanced technologies to meet evolving societal needs. With a heightened emphasis on occupants’ health and well-being, these buildings serve as hubs for technological convergence, facilitating seamless connectivity and intelligent data analysis and management. Within this context, environmental monitoring emerges as a foundational element, pivotal to all aspects of building management. This article provides findings from the nationally funded RE-START project, which focuses on shared public buildings, with special regard to educational and medical facilities. The project explores enhanced indoor air quality monitoring, focusing on CO2 concentration that is directly correlated with occupancy, as a fundamental element for developing health and safety protocols, energy efficiency strategies, the integration of smart building technologies, and data-driven energy management. The intersection of environmental monitoring, energy efficiency, security, and IoT technologies in in indoor spaces is relevant. The outcomes of the study reveal the delicate nature of all the involved components, which need to be carefully developed in an integrated manner.

21 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Alessandro FrancoAlessandro Franco
Alessandro Franco
ECEmanuele Crisostomi
Emanuele Crisostomi
Stefano DalmianiStefano Dalmiani
Stefano Dalmiani
RPRoberta Poletti
Roberta Poletti
Shared public buildings have become centers of innovation, integrating advanced technologies to meet evolving societal needs. With a heightened emphasis on occupants’ health and well-being, these buildings serve as hubs for technological convergence, facilitating seamless connectivity and intelligent data analysis and management. Within this context, environmental monitoring emerges as a foundational element, pivotal to all aspects of building management. This article provides findings from the nationally funded RE-START project, which focuses on shared public buildings, with special regard to educational and medical facilities. The project explores enhanced indoor air quality monitoring, focusing in particular on CO2 concentration that is directly correlated with occupancy, as a fundamental element for developing health and safety protocols, energy efficiency strategies, integration of smart building technologies, and data-driven energy management. The intersection of environmental monitoring, energy efficiency, security, and IoT technologies in in indoor spaces are relevant. The outcomes of the study reveal the delicate nature of all the involved components, that need to be carefully developed in an integrated manner.